New therapies for early Alzheimer’s disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease.
Pharmalittle: Roche buys Roivant bowel disease drug for $7.1 billion; AstraZeneca CEO calls report of imminent retirement ‘fake news’
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because — you know what we will
October 23, 2023